The Global Ophthalmology Awards Program demonstrates Bayer's commitment to the ophthalmology community and to advancing state of the art ophthalmic care. As award decisions are taken by the independent Grants Review and Awards Committee, and based on an applicant’s merit and eligibility, all decisions are final and not subject to appeal.
The Research Award is designed to support a wide range of research projects (basic and clinical) in the field of retinal ophthalmology, including diagnosis and assessment, treatment, surgery, quality of life, and mechanisms of action.
Applicants must have an MD or PhD and be affiliated with a facility that carries out research in ophthalmology, including medical schools, universities, hospitals, treatment centres or laboratories.
Applicants will be judged according to the following criteria:
- Merit - Scientific merit of the experimental approach and its relevance to the ophthalmology/research community
- Innovation - Novelty of the study design, methodology and objectives
- Impact - Impact on clinical or scientific understanding of retinal disorders
- Environment - Quality of the research environment
Research Awards will provide funding of up to US$50,000 per award for one year in the majority of cases. Additional funding will be considered.
Payment must be made to the awardee's institution rather than directly to the awardee. The majority of the funding will be made available at the start of the one year project, with the remainder provided at the end of the project. Receipt of satisfactory interim progress and financial reports are necessary before payment of subsequent instalments are made.